San Diego waterfront during ASH 2024
Goodbye, San Diego.Adam Feuerstein / STAT

By STAT Staff, Adam Feuerstein, Angus Chen, and Meghana Keshavan

Dec. 10, 2024

This roundup of news from the ASH 2024 conference first appeared in STAT’s “ASH in 30” newsletter.

Is it Tuesday already? This is the last day of the American Society of Hematology meeting. Thanks for stopping by to read all of our coverage. San Diego has been a wonderful host city, and we look forward to being in Orlando next December. 

advertisement

Biotech fights are very entertaining 

The feud between Arcellx and Legend Biotech over their anti-BCMA CAR-T therapies for multiple myeloma is getting extra spicy. 

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$20

for 3 months, then $399/year

$20 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe
, , ,
Submit a correction requestReprints

  1. STAT Staff

  2. Adam Feuerstein

    Senior Writer, Biotech

    Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard.

  3. Angus Chen

    Cancer Reporter

    Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His work has been recognized by national Edward R. Murrow awards, the June L. Biedler prize for cancer journalism, and more.

  4. Meghana Keshavan

    Biotech Correspondent

    Meghana Keshavan covers biotech and contributes to The Readout newsletter.